• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BioDelivery names Ginsberg as biz dev veep | Personnel Moves, Dec. 14, 2016

December 14, 2016 By Sarah Faulkner

BioDelivery names Ginsberg as biz dev veep | Personnel Moves, Dec. 14, 2016BioDelivery Sciences International (NSDQ:BDSI) said today that it named Peter Ginsberg as its VP of business development.

Prior to joining the Raleigh, N.C.-based company, Ginsberg led business development at United Therapeutics and directed a $350 million sale of the company’s priority review voucher. He has also served as VP of business & technology development for the North Carolina Biotechnology Center, advising and financing emerging biotech companies. Ginsberg also lead acquisitions and licensing transactions for SurModics as the VP of business development & strategic planning.

“We are very pleased to have Peter join BDSI given the depth and level of experience he brings as we look to enhance our focus on business development opportunities, particularly given the recent reacquisition of Belbuca,” president & CEO Mark Sirgo said in prepared remarks. “This hire will allow us to augment our efforts behind business opportunities for Belbuca and Bunavail both outside as well as inside the U.S.”

Yesterday, BioDelivery said its clonidine topical gel for pain relief in patients with diabetic neuropathy failed in a phase IIb clinical trial and that the company will halt any further development of the painkiller. The new data comes 1 week after the company said it reacquired the rights to the Belbuca opioid patch from Endo Pharmaceuticals.

Filed Under: Featured, Pain Management, Personnel, Pharmaceuticals Tagged With: BioDelivery Sciences International

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS